These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34525396)

  • 1. The mitochondria-targeting antioxidant MitoQ alleviated lipopolysaccharide/ d-galactosamine-induced acute liver injury in mice.
    Hu K; Xiao L; Li L; Shen Y; Yang Y; Huang J; Wang Y; Zhang L; Wen S; Tang L
    Immunol Lett; 2021 Dec; 240():24-30. PubMed ID: 34525396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway.
    Peng X; Yang Y; Tang L; Wan J; Dai J; Li L; Huang J; Shen Y; Lin L; Gong X; Zhang L
    Biomed Pharmacother; 2020 May; 125():110020. PubMed ID: 32106375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herbal formula CGX ameliorates LPS/D-galactosamine-induced hepatitis.
    Shin JW; Wang JH; Park HJ; Choi MK; Kim HG; Son CG
    Food Chem Toxicol; 2011 Jun; 49(6):1329-34. PubMed ID: 21414374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
    Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
    Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant mitoquinone ameliorates EtOH-LPS induced lung injury by inhibiting mitophagy and NLRP3 inflammasome activation.
    Sang W; Chen S; Lin L; Wang N; Kong X; Ye J
    Front Immunol; 2022; 13():973108. PubMed ID: 36059543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep deprivation aggravated lipopolysaccharide/D-galactosamine-induced acute liver injury by suppressing melatonin production.
    Liu L; Zhang L; Li L; Chen M; Wang Z; Shen Y; Huang J; Tang L
    Inflamm Res; 2020 Nov; 69(11):1133-1142. PubMed ID: 32809047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
    Ai Q; Jing Y; Jiang R; Lin L; Dai J; Che Q; Zhou D; Jia M; Wan J; Zhang L
    Int Immunopharmacol; 2014 Jul; 21(1):200-7. PubMed ID: 24830863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
    Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice.
    Liu A; Shen Y; Du Y; Chen J; Pei F; Fu W; Qiao J
    Microb Pathog; 2018 Dec; 125():418-422. PubMed ID: 30290266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caloric restriction mimetic 2-deoxyglucose alleviated lethal liver injury induced by lipopolysaccharide/D-galactosamine in mice.
    Che Q; Lin L; Ai Q; Ge P; Dai J; Jiang R; Zhou D; Wan J; Zhang L
    Biochem Biophys Res Commun; 2015 Apr; 459(3):541-6. PubMed ID: 25749337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of garcinol in mice with lipopolysaccharide/D-galactosamine-induced apoptotic liver injury.
    Jing Y; Ai Q; Lin L; Dai J; Jia M; Zhou D; Che Q; Wan J; Jiang R; Zhang L
    Int Immunopharmacol; 2014 Apr; 19(2):373-80. PubMed ID: 24560905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation.
    Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X
    Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
    Yang C; He L; Wang C; Huang Y; Wang A; Li X; Ao J
    Int Immunopharmacol; 2019 Jul; 72():367-373. PubMed ID: 31030092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
    Lowes DA; Thottakam BM; Webster NR; Murphy MP; Galley HF
    Free Radic Biol Med; 2008 Dec; 45(11):1559-65. PubMed ID: 18845241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panaxynol from
    Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
    Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine specific demethylase 1 inhibitor alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury.
    Wang X; Sun Y; Fu Y; Wu H; Chen Y; Ye Y; Zhou Q; He L; Zhou E; Wang J; Yang Z
    Eur J Pharmacol; 2022 Oct; 932():175227. PubMed ID: 36007605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lycopene Prevents Mitochondrial Dysfunction during d-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure in Albino Rats.
    Sheriff SA; Shaik Ibrahim S; Devaki T; Chakraborty S; Agarwal S; Pérez-Sánchez H
    J Proteome Res; 2017 Sep; 16(9):3190-3199. PubMed ID: 28758404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
    Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
    Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
    Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
    BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
    Hu JJ; Wang H; Pan CW; Lin MX
    Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.